Table 4.
Effect | Univariable Models |
Multivariable Model* |
||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Length of drug injection (yrs)** | 1.14 | 0.93–1.41 | 0.206 | 1.10 | 0.88–1.37 | 0.396 |
Sharing drug solution through frontloading, last injection | 4.33 | 1.24–15.21 | 0.022 | 3.82 | 1.06–13.80 | 0.041 |
No. of sexual partners, past 12 months | 1.03 | 0.96–1.11 | 0.383 | |||
Having had sex with a female sex worker, past 12 months | 1.07 | 0.52–2.22 | 0.853 | |||
Having Chlamydial infection (PCR) or HSV-2 infection (EIA) | 2.60 | 0.93–7.29 | 0.069 | 2.15 | 0.69–6.70 | 0.188 |
Being vaccinated against hepatitis B, at least one dose | 0.57 | 0.17–1.95 | 0.372 | 0.89 | 0.23–3.46 | 0.864 |
OR denotes odds ratio; CI, confidence interval; PCR, polymerase chain reaction; EIA, enzyme-linked immunosorbent assay;
Multivariable model included Length of drug injection, Sharing drug solution through frontloading at last injection, Having chlamydial infection or HSV-2 infection, and Being vaccinated against hepatitis B;
Odds ratio for one year increase.